Bioventus Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Bioventus stock has a consensus rating of "Strong Buy" and an average price target of $14.8. The average 1-year stock price forecast is 60.87% higher than the current stock price, while the lowest is $14 (+52.17%) and the highest is $16 (+73.91%).

Price Target: $14.8 (+60.87%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$14	$14.8	$15	$16
Change	+52.17%	+60.87%	+63.04%	+73.91%

Analyst Ratings

The average analyst rating for Bioventus stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	1	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington	Barrington	Buy Maintains $14	Buy	Maintains	$14	+52.17%	May 22, 2026
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 22, 2026
Caitlin Roberts Canaccord Genuity	Canaccord Genuity	Buy Maintains $15	Buy	Maintains	$15	+63.04%	May 11, 2026
Lawrence Solow CJS Securities	CJS Securities	Buy Initiates $14	Buy	Initiates	$14	+52.17%	Mar 27, 2026

Financial Forecast

Revenue This Year

605.30M

from 568.09M

6.55%

from 568.09M

Revenue Next Year

645.46M

from 605.30M

6.63%

from 605.30M

EPS This Year

0.78

from 0.68

14.12%

from 0.68

EPS Next Year

0.91

from 0.78

16.75%

from 0.78

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	430.90M	512.12M	512.35M	573.28M	568.09M	605.30M
Revenue Growth	34.17%	18.85%	0.05%	11.89%	-0.91%	6.55%
Gross Profit	302.71M	331.08M	328.19M	388.23M	388.16M	425.04M
Gross Margin	70.25%	64.65%	64.06%	67.72%	68.33%	70.22%
Operating Income	21.05M	-34.66M	2.03M	36.63M	56.34M	108.10M
Net Income	19.38M	-158.70M	-156.23M	-36.13M	22.73M	29.33M
EPS	-	-	-	-	0.68	0.78
EPS Growth	-	-	-	-	38.78%	14.12%
Forward PE	21.50	17.17	21.82	20.00	9.79	11.86
Free Cash Flow	-25.11M	92.14M	-108.45M	68.24M	28.15M	84.16M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	607.3M
Avg	605.3M
Low	602.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	6.9%
Avg	6.6%
Low	6.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.78
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	14.1%
Low	-